Search research articles
Contact Us
Filters
Showing results (111-120 of 204) with videos related to
Page
of 21
Sort By:
Blood Cells, Molecules & Diseases
|
September 19, 2009
Human CD34+ cells are capable of generating normal and JAK2V617F positive endothelial like cells in vivo
Selcuk Sozer, Takefumi Ishii, Maria Isabel Fiel, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 5, 2024
Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy
Shivani Handa, Ganesh Sivakumar, Andrew Srisuwananukorn, et al.
Blood
|
July 11, 2025
Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression
Lilian Varricchio, Gohar Mosoyan, Sebastian El Ghaity-Beckley, et al.
Experimental Hematology
|
May 18, 2004
Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells
Il-Hoan Oh, Mary E Fabry, R Keith Humphries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia
Margherita Massa, Vittorio Rosti, Isabella Ramajoli, et al.
Cancer Research
|
July 10, 2007
Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis
Jun Shi, Yan Zhao, Takefumi Ishii, et al.
Blood Advances
|
December 20, 2018
Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53
Bridget K Marcellino, Ronald Hoffman, Joseph Tripodi, et al.
Frontiers in Cell and Developmental Biology
|
January 1, 2021
Limited Mitochondrial Activity Coupled With Strong Expression of CD34, CD90 and EPCR Determines the Functional Fitness of <i>ex vivo</i> Expanded Human Hematopoietic Stem Cells
Luena Papa, Mansour Djedaini, Tiphaine C Martin, et al.
Blood
|
May 3, 2007
Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis
Stefan O Ciurea, Delwin Merchant, Nadim Mahmud, et al.
The Lancet. Haematology
|
December 31, 2021
Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials
Gina L Mazza, Carolyn Mead-Harvey, John Mascarenhas, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 204) with videos related to
Sort By:
Page
of 21
Blood Cells, Molecules & Diseases
|
September 19, 2009
Human CD34+ cells are capable of generating normal and JAK2V617F positive endothelial like cells in vivo
Selcuk Sozer, Takefumi Ishii, Maria Isabel Fiel, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 5, 2024
Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy
Shivani Handa, Ganesh Sivakumar, Andrew Srisuwananukorn, et al.
Blood
|
July 11, 2025
Thrombocytopenia in myelofibrosis is characterized by inflammatory megakaryocytes with reduced G6B expression
Lilian Varricchio, Gohar Mosoyan, Sebastian El Ghaity-Beckley, et al.
Experimental Hematology
|
May 18, 2004
Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells
Il-Hoan Oh, Mary E Fabry, R Keith Humphries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia
Margherita Massa, Vittorio Rosti, Isabella Ramajoli, et al.
Cancer Research
|
July 10, 2007
Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis
Jun Shi, Yan Zhao, Takefumi Ishii, et al.
Blood Advances
|
December 20, 2018
Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53
Bridget K Marcellino, Ronald Hoffman, Joseph Tripodi, et al.
Frontiers in Cell and Developmental Biology
|
January 1, 2021
Limited Mitochondrial Activity Coupled With Strong Expression of CD34, CD90 and EPCR Determines the Functional Fitness of <i>ex vivo</i> Expanded Human Hematopoietic Stem Cells
Luena Papa, Mansour Djedaini, Tiphaine C Martin, et al.
Blood
|
May 3, 2007
Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis
Stefan O Ciurea, Delwin Merchant, Nadim Mahmud, et al.
The Lancet. Haematology
|
December 31, 2021
Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials
Gina L Mazza, Carolyn Mead-Harvey, John Mascarenhas, et al.
Page
of 21